Advertisement
Advertisement
CNTX
Context Therapeutics Inc. Common Stock
0.58
USDSponsored
+0.02
+3.57%
Jun 26, 16:00 UTC -4
Closed
After-Market
0.58
+0.01
+0.86%
CNTX Earnings Reports
Positive Surprise Ratio
CNTX beat 9 of 17 last estimates.
53%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.09
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Context Therapeutics Inc. Common Stock earnings per share and revenue
On May 06, 2026, CNTX reported earnings of -0.09 USD per share (EPS) for Q1 26, beating the estimate of -0.11 USD, resulting in a 24.81% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.32% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.09 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Context Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Context Therapeutics Inc. Common Stock reported EPS of -$0.09, beating estimates by 24.81%, and revenue of $0.00, 0% as expectations.
How did the market react to Context Therapeutics Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -3.32%, changed from $2.41 before the earnings release to $2.33 the day after.
When is Context Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Context Therapeutics Inc. Common Stock's next earnings report?
Based on --
analysts, Context Therapeutics Inc. Common Stock is expected to report EPS of -$0.09 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement